{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:44:23Z","timestamp":1778582663626,"version":"3.51.4"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jns.2021.117417","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:18:28Z","timestamp":1617257908000},"page":"117417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development"],"prefix":"10.1016","volume":"424","author":[{"given":"Meng-Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Opal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Han","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12311-016-0836-3","article-title":"The initial symptom and motor progression in spinocerebellar ataxias","volume":"16","author":"Luo","year":"2017","journal-title":"Cerebellum"},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mdc3.12042","article-title":"Movement disorders in autosomal dominant cerebellar ataxias: a systematic review","volume":"1","author":"Rossi","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(18)30042-5","article-title":"Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study","volume":"17","author":"Diallo","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0020","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1086\/302067","article-title":"Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations","volume":"63","author":"Takano","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ajmg.10514","article-title":"Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients","volume":"114","author":"Maruyama","year":"2002","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12311-008-0028-x","article-title":"Sporadic ataxias in Japan\u2014a population-based epidemiological study","volume":"7","author":"Tsuji","year":"2008","journal-title":"Cerebellum"},{"key":"10.1016\/j.jns.2021.117417_bb0035","article-title":"DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder","author":"Chaudhry","year":"2020","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","article-title":"Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond","volume":"9","author":"Durr","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.117417_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1750-1172-8-177","article-title":"Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study","volume":"8","author":"Ashizawa","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.0b013e31822e7ca0","article-title":"The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study","volume":"77","author":"Jacobi","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.1996.tb00173.x","article-title":"Clinical features and natural history of spinocerebellar ataxia type 1","volume":"93","author":"Sasaki","year":"1996","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2021.117417_bb0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13023-014-0118-4","article-title":"A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan","volume":"9","author":"Yasui","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0065","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/mds.22627","article-title":"Progression of ataxia in patients with Machado-Joseph disease","volume":"24","author":"Franca","year":"2009","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.25297","article-title":"Structural signature of SCA3: from presymptomatic to late disease stages","volume":"84","author":"Rezende","year":"2018","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0075","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/mds.28113","article-title":"A 5-year longitudinal clinical and magnetic resonance imaging study in spinocerebellar Ataxia type 3","volume":"35","author":"Piccinin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.117417_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-319-71779-1_13","article-title":"Clinical features of Machado-Joseph disease","volume":"1049","author":"Mendonca","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0085","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/mds.23809","article-title":"Comparison of cerebellar ataxias: a three-year prospective longitudinal assessment","volume":"26","author":"Lee","year":"2011","journal-title":"Mov. Disord."},{"issue":"22","key":"10.1016\/j.jns.2021.117417_bb0090","doi-asserted-by":"crossref","first-page":"e3036","DOI":"10.1212\/WNL.0000000000010986","article-title":"Gray matter atrophy patterns within the cerebellum-neostriatum-cortical network in SCA3","volume":"95","author":"Guo","year":"2020","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jns.2021.117417_bb0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: prospects and challenges for therapy development","volume":"14","author":"Ashizawa","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International cooperative Ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The Ataxia neuropharmacology committee of the world federation of neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0105","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-Hubsch","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2021.117417_bb0110","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/mds.22681","article-title":"Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS","volume":"24","author":"Schmahmann","year":"2009","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12311-017-0855-8","article-title":"NESSCA validation and responsiveness of several rating scales in spinocerebellar Ataxia type 2","volume":"16","author":"Monte","year":"2017","journal-title":"Cerebellum"},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1468-1331.2008.02078.x","article-title":"A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)","volume":"15","author":"Kieling","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13023-016-0447-6","article-title":"A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7","volume":"11","author":"Moriarty","year":"2016","journal-title":"Orphanet. J. Rare Dis."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.jns.2021.117417_bb0135","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","article-title":"Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms","volume":"71","author":"Schmitz-Hubsch","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12311-012-0421-3","article-title":"Inventory of non-Ataxia signs (INAS): validation of a new clinical assessment instrument","volume":"12","author":"Jacobi","year":"2013","journal-title":"Cerebellum"},{"issue":"Pt 5","key":"10.1016\/j.jns.2021.117417_bb0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/brain\/awn059","article-title":"Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment","volume":"131","author":"du Montcel","year":"2008","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.wnl.0000324863.76290.19","article-title":"SCA functional index: a useful compound performance measure for spinocerebellar ataxia","volume":"71","author":"Schmitz-Hubsch","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/brain\/awx317","article-title":"The cerebellar cognitive affective\/Schmahmann syndrome scale","volume":"141","author":"Hoche","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0160","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/mds.23698","article-title":"Depression comorbidity in spinocerebellar ataxia","volume":"26","author":"Schmitz-Hubsch","year":"2011","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0165","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/archneur.61.11.1757","article-title":"Cognitive impairments in Machado-Joseph disease","volume":"61","author":"Kawai","year":"2004","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/jnp.2006.18.3.420","article-title":"Depressive and memory symptoms as presenting features of spinocerebellar ataxia","volume":"18","author":"McMurtray","year":"2006","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12311-011-0318-6","article-title":"Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features","volume":"11","author":"Braga-Neto","year":"2012","journal-title":"Cerebellum"},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jns.2021.117417_bb0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2015.11.021","article-title":"Depression and clinical progression in spinocerebellar ataxias","volume":"22","author":"Lo","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jns.2021.117417_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S.D.O. Health","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jns.2021.117417_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient Relat. Outcome Meas."},{"issue":"Pt 8","key":"10.1016\/j.jns.2021.117417_bb0210","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/brain\/awh201","article-title":"Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study","volume":"127","author":"Guerrini","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/acn3.504","article-title":"Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2","volume":"5","author":"Reetz","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.jns.2021.117417_bb0220","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awv064","article-title":"Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich\u2019s ataxia","volume":"138","author":"Stefanescu","year":"2015","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0225","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2967\/jnumed.111.101543","article-title":"PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17","volume":"53","author":"Brockmann","year":"2012","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0230","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3174\/ajnr.A2387","article-title":"Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status","volume":"32","author":"Eichler","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"8","key":"10.1016\/j.jns.2021.117417_bb0235","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneur.58.8.1257","article-title":"Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease","volume":"58","author":"Etchebehere","year":"2001","journal-title":"Arch. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.jns.2021.117417_bb0240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/brain\/aws369","article-title":"Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6","volume":"136","author":"Reetz","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00415-013-7186-6","article-title":"White matter damage is related to ataxia severity in SCA3","volume":"261","author":"Kang","year":"2014","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1552-6569.2011.00614.x","article-title":"Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study","volume":"22","author":"D\u2019Abreu","year":"2012","journal-title":"J. Neuroimaging"},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.parkreldis.2011.04.008","article-title":"Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study","volume":"17","author":"Goel","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.jns.2021.117417_bb0260","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.25451","article-title":"A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3","volume":"28","author":"Guimaraes","year":"2013","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12311-009-0150-4","article-title":"Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17","volume":"9","author":"Reetz","year":"2010","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0270","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroimage.2009.07.027","article-title":"Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6","volume":"49","author":"Schulz","year":"2010","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0275","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.49.6.1605","article-title":"Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings","volume":"49","author":"Koide","year":"1997","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0280","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3174\/ajnr.A4343","article-title":"Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study","volume":"36","author":"Mascalchi","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0285","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00415-017-8705-7","article-title":"Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy","volume":"265","author":"Sugiyama","year":"2018","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0290","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00415-006-0383-9","article-title":"Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: a voxel-based FDG-positron emission tomography analysis","volume":"254","author":"Wang","year":"2007","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/ene.12559","article-title":"Cerebral cortex involvement in Machado-Joseph disease","volume":"22","author":"de Rezende","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12311-014-0619-7","article-title":"Spinal cord damage in Machado-Joseph disease","volume":"14","author":"Fahl","year":"2015","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.410430215","article-title":"Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1","volume":"43","author":"Mascalchi","year":"1998","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.117417_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047925","article-title":"Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy","volume":"7","author":"Lirng","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2005.05.015","article-title":"(1)H magnetic resonance spectroscopy of autosomal ataxias","volume":"1049","author":"Viau","year":"2005","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0320","first-page":"511","article-title":"Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"36","author":"Lei","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0325","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0404.2011.01620.x","article-title":"MR spectroscopy and atrophy in gluten, Friedreich\u2019s and SCA6 ataxias","volume":"126","author":"Hadjivassiliou","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"21","key":"10.1016\/j.jns.2021.117417_bb0330","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123193","article-title":"Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles","volume":"3","author":"Friedrich","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0335","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410390214","article-title":"Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions","volume":"39","author":"Gilman","year":"1996","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2021.117417_bb0340","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.62.8.1280","article-title":"Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6","volume":"62","author":"Wullner","year":"2005","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173275","article-title":"Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography","volume":"12","author":"Oh","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0350","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410410407","article-title":"Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds","volume":"41","author":"Soong","year":"1997","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0355","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp.64.4.499","article-title":"Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease","volume":"64","author":"Soong","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0360","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneur.58.2.300","article-title":"Metabolic characterization of spinocerebellar ataxia type 6","volume":"58","author":"Soong","year":"2001","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0365","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.parkreldis.2011.01.015","article-title":"Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia","volume":"17","author":"Yun","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0370","first-page":"994","article-title":"Decreased dopamine transporter binding in Machado-Joseph disease","volume":"41","author":"Yen","year":"2000","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12311-015-0716-2","article-title":"Psychosis in Machado-Joseph disease: clinical correlates, pathophysiological discussion, and functional brain imaging. Expanding the cerebellar cognitive affective syndrome","volume":"15","author":"Braga-Neto","year":"2016","journal-title":"Cerebellum"},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0380","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneur.61.6.933","article-title":"Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6","volume":"61","author":"Honjo","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.117417_bb0385","doi-asserted-by":"crossref","first-page":"413098","DOI":"10.1155\/2015\/413098","article-title":"Cerebrospinal fluid biomarkers in spinocerebellar Ataxia: a pilot study","volume":"2015","author":"Brouillette","year":"2015","journal-title":"Dis. Markers"},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0390","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","article-title":"Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study","volume":"265","author":"Wilke","year":"2018","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0395","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0400","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0405","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00415-020-10274-y","article-title":"PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study","volume":"268","author":"Gonsior","year":"2021","journal-title":"J. Neurol."},{"issue":"566","key":"10.1016\/j.jns.2021.117417_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb7086","article-title":"Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3","volume":"12","author":"Prudencio","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jns.2021.117417_bb0415","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fneur.2019.01094","article-title":"Carboxyl terminus of Hsp70-interacting protein is increased in serum and cerebrospinal fluid of patients with spinocerebellar Ataxia type 3","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0420","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12311-015-0719-z","article-title":"Cytokines in Machado Joseph disease\/spinocerebellar Ataxia 3","volume":"15","author":"da Silva Carvalho","year":"2016","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00207454.2013.827679","article-title":"MicroRNA profiling in the serums of SCA3\/MJD patients","volume":"124","author":"Shi","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0430","first-page":"504","article-title":"Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"36","author":"Zhou","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1\u20132","key":"10.1016\/j.jns.2021.117417_bb0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cccn.2004.08.010","article-title":"S100B and NSE serum concentrations in Machado Joseph disease","volume":"351","author":"Tort","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"15","key":"10.1016\/j.jns.2021.117417_bb0440","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1093\/hmg\/ddr197","article-title":"FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3","volume":"20","author":"Araujo","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2021.117417_bb0445","doi-asserted-by":"crossref","first-page":"701758","DOI":"10.1155\/2014\/701758","article-title":"From pathways to targets: understanding the mechanisms behind polyglutamine disease","volume":"2014","author":"Weber","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.jns.2021.117417_bb0450","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/jnr.22011","article-title":"Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease","volume":"87","author":"Yu","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0455","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mrgentox.2013.06.023","article-title":"Association between Machado-Joseph disease and oxidative stress biomarkers","volume":"757","author":"Pacheco","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jns.2021.117417_bb0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fneur.2017.00485","article-title":"Peripheral oxidative stress biomarkers in spinocerebellar Ataxia type 3\/Machado-Joseph disease","volume":"8","author":"de Assis","year":"2017","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0465","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0470","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/mds.23428","article-title":"Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3","volume":"26","author":"Saute","year":"2011","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030390","article-title":"Altered plasma acylcarnitines and amino acids profile in spinocerebellar Ataxia type 7","volume":"10","author":"Nambo-Venegas","year":"2020","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0480","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/epi-2019-0081","article-title":"Identification of a potential exosomal biomarker in spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"11","author":"Hou","year":"2019","journal-title":"Epigenomics"},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0485","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1007\/s12035-019-1480-y","article-title":"Wide profiling of circulating MicroRNAs in spinocerebellar Ataxia type 7","volume":"56","author":"Borgonio-Cuadra","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0490","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/VES-160579","article-title":"Vestibulo-ocular reflex dynamics with head-impulses discriminates spinocerebellar ataxias types 1, 2 and 3 and Friedreich ataxia","volume":"26","author":"Luis","year":"2016","journal-title":"J. Vestib. Res."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0495","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/mds.25464","article-title":"Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features","volume":"28","author":"Kim","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0500","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cns.12676","article-title":"Oculomotor deficits in spinocerebellar ataxia type 3: potential biomarkers of preclinical detection and disease progression","volume":"23","author":"Wu","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"1\u20132","key":"10.1016\/j.jns.2021.117417_bb0505","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2007.07.013","article-title":"Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2","volume":"263","author":"Velazquez Perez","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0510","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00001756-200004070-00014","article-title":"Electrophysiological studies in spinocerebellar ataxia type 6: a statistical approach","volume":"11","author":"Kumagai","year":"2000","journal-title":"Neuroreport"},{"issue":"Pt 12","key":"10.1016\/j.jns.2021.117417_bb0515","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/brain\/120.12.2141","article-title":"Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3","volume":"120","author":"Abele","year":"1997","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0520","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.parkreldis.2012.11.002","article-title":"Alterations in cortical excitability and central motor conduction time in spinocerebellar ataxias 1, 2 and 3: a comparative study","volume":"19","author":"Jhunjhunwala","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0525","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.65.4.530","article-title":"Electrophysiological features of central motor conduction in spinocerebellar atrophy type 1, type 2, and Machado-Joseph disease","volume":"65","author":"Yokota","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.jns.2021.117417_bb0530","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/brain\/awf023","article-title":"Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect","volume":"125","author":"Schwenkreis","year":"2002","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0535","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.clinph.2016.09.005","article-title":"Motor cortical dysfunction develops in spinocerebellar ataxia type 3","volume":"127","author":"Farrar","year":"2016","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0540","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1388-2457(02)00378-4","article-title":"Prolonged cortical relay time of long latency reflex and central motor conduction in patients with spinocerebellar ataxia type 6","volume":"114","author":"Lee","year":"2003","journal-title":"Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0545","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1152\/jn.00745.2012","article-title":"Cerebellar motor learning: are environment dynamics more important than error size?","volume":"110","author":"Gibo","year":"2013","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0550","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1152\/jn.00822.2009","article-title":"Size of error affects cerebellar contributions to motor learning","volume":"103","author":"Criscimagna-Hemminger","year":"2010","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0555","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1152\/jn.00451.2017","article-title":"The cerebellum does more than sensory prediction error-based learning in sensorimotor adaptation tasks","volume":"118","author":"Butcher","year":"2017","journal-title":"J. Neurophysiol."},{"issue":"28","key":"10.1016\/j.jns.2021.117417_bb0560","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1073\/pnas.1716489115","article-title":"Tandem internal models execute motor learning in the cerebellum","volume":"115","author":"Honda","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2021.117417_bb0565","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2020.00179","article-title":"Assessment and rating of motor cerebellar ataxias with the Kinect v2 depth sensor: extending our appraisal","volume":"11","author":"Honda","year":"2020","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.117417_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132983","article-title":"A new method for functional evaluation of motor commands in patients with cerebellar Ataxia","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 7","key":"10.1016\/j.jns.2021.117417_bb0575","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/brain\/awu115","article-title":"Predicting and correcting ataxia using a model of cerebellar function","volume":"137","author":"Bhanpuri","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0580","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12984-019-0522-z","article-title":"Effects of repeated waist-pull perturbations on gait stability in subjects with cerebellar ataxia","volume":"16","author":"Aprigliano","year":"2019","journal-title":"J. Neuroeng. Rehabil."},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0585","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12984-018-0451-2","article-title":"Kinect-based assessment of proximal arm non-use after a stroke","volume":"15","author":"Bakhti","year":"2018","journal-title":"J. Neuroeng. Rehabil."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0590","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/jn.2001.85.2.759","article-title":"Selection and coordination of human locomotor forms following cerebellar damage","volume":"85","author":"Earhart","year":"2001","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119376","article-title":"Quantitative evaluation of human cerebellum-dependent motor learning through prism adaptation of hand-reaching movement","volume":"10","author":"Hashimoto","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118592","article-title":"The 3-second rule in hereditary pure cerebellar ataxia: a synchronized tapping study","volume":"10","author":"Matsuda","year":"2015","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.jns.2021.117417_bb0605","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1523\/JNEUROSCI.2622-06.2006","article-title":"Cerebellar contributions to locomotor adaptations during splitbelt treadmill walking","volume":"26","author":"Morton","year":"2006","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0610","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1109\/TNSRE.2019.2911657","article-title":"Quantitative evaluation of cerebellar Ataxia through automated assessment of upper limb movements","volume":"27","author":"Tran","year":"2019","journal-title":"IEEE Trans. Neural. Syst. Rehabil. Eng."},{"key":"10.1016\/j.jns.2021.117417_bb0615","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fneur.2020.00902","article-title":"Collaborative efforts for spinocerebellar Ataxia research in the United States: CRC-SCA and READISCA","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.117417_bb0620","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nicl.2016.11.007","article-title":"CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3","volume":"13","author":"Huang","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0625","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/mds.23067","article-title":"Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status","volume":"25","author":"Oz","year":"2010","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0630","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","article-title":"Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy","volume":"10","author":"Oz","year":"2011","journal-title":"Cerebellum"},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0635","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.25212","article-title":"Neurochemical abnormalities in premanifest and early spinocerebellar ataxias","volume":"83","author":"Joers","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117417_bb0640","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12311-013-0527-2","article-title":"Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1","volume":"13","author":"Doss","year":"2014","journal-title":"Cerebellum"},{"issue":"10","key":"10.1016\/j.jns.2021.117417_bb0645","article-title":"Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jns.2021.117417_bb0650","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/mds.22056","article-title":"PET study of brain acetylcholinesterase in cerebellar degenerative disorders","volume":"23","author":"Hirano","year":"2008","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2021.117417_bb0655","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/mds.20159","article-title":"Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study","volume":"19","author":"Boesch","year":"2004","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0660","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.20054","article-title":"Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism","volume":"55","author":"Varrone","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2021.117417_bb0665","first-page":"1518","article-title":"Decreased benzodiazepine receptor binding in Machado-Joseph disease","volume":"39","author":"Ishibashi","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jns.2021.117417_bb0670","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40673-014-0017-4","article-title":"The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type","volume":"1","author":"Chen","year":"2014","journal-title":"Cerebellum Ataxias"},{"issue":"3","key":"10.1016\/j.jns.2021.117417_bb0675","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.20846","article-title":"Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging","volume":"25","author":"Boesch","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0680","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.26181","article-title":"In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7","volume":"30","author":"Adanyeguh","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.117417_bb0685","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1552-6569.2008.00260.x","article-title":"Axonal dysfunction in the deep white matter in Machado-Joseph disease","volume":"19","author":"D\u2019Abreu","year":"2009","journal-title":"J. Neuroimaging"},{"issue":"4","key":"10.1016\/j.jns.2021.117417_bb0690","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmri.1078","article-title":"Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6","volume":"13","author":"Boesch","year":"2001","journal-title":"J. Magn. Reson. Imaging"},{"issue":"6","key":"10.1016\/j.jns.2021.117417_bb0695","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12311-015-0667-7","article-title":"High serum GFAP levels in SCA3\/MJD may not correlate with disease progression","volume":"14","author":"Shi","year":"2015","journal-title":"Cerebellum"},{"issue":"10","key":"10.1016\/j.jns.2021.117417_bb0700","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.clinph.2004.04.025","article-title":"Impaired P50 sensory gating in Machado-Joseph disease","volume":"115","author":"Ghisolfi","year":"2004","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.jns.2021.117417_bb0705","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.clinph.2008.01.008","article-title":"Movement-related cortical potentials in patients with Machado-Joseph disease","volume":"119","author":"Lu","year":"2008","journal-title":"Clin. Neurophysiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:55:31Z","timestamp":1758383731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":141,"alternative-id":["S0022510X21001106"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117417","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117417"}}